osimertinib
astrazeneca
['osimertinib']
a summary of ongoing research wrt to neoadj osimertinib with classical egfr activating mutations at #asco23 by . 
Physician | Chief Fellow @McGovernHemeOnc| IM- @UMassChan @baystateIM l Interests: thoracic oncology #LCSM, #globaloncology, #meded, SCD | Tweets are mine